In Indian currency, Pang’s deal translates to over Rs 1,600 crore, while Bansal’s offer is worth around Rs 800 crore.

A major scientific advance in protein modeling developed by Microsoft Research AI for Science, has been published in Science.

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

Artificial intelligence is now designing custom proteins in seconds—a process that once took years—paving the way for cures to diseases like cancer and antibiotic-resistant infections. Australian ...

Technology can be harnessed to design novel and enhanced molecules that address challenges in biotechnology or medicine.

The start-up, which aims to raise tens of millions of US dollars in an angel funding round, hopes to compete globally, ...

AI is fundamental to the competitive strategies of the most advanced healthcare and pharmaceutical firms. Here is how they ...

Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...

Using this information, the model can then tell us the probability of a drug-protein interaction that we did not previously ...

The oncology drug created by Isomorphic Labs using Google DeepMind’s AlphaFold 3 tool could be pivotal for cancer treatment.

Isomorphic Labs, backed by Google's parent company Alphabet, is preparing for its first human clinical trials for cancer drugs designed entirely by artificial intelligence.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...